Pre-market
Loading markets…
Stocks/TSX-V/MPH

Medicure Inc (MPH : TSX-V)

Common Stock

$4.23

CAD

-0.07 (-1.63%)

Last updated: 2026-11-02

Follow MPH

MPH

Medicure Inc

Source:WealthAwesomeWealthAwesome
↑ $1.54 (57.25%)
30 day period
$2.63$3.54$4.44Sep 16Oct 13Nov 2

Performance

1 Day

-1.63%

1 Week

-3.86%

1 Month

+44.86%

YTD

+271.05%

Key Statistics

Market Cap

$44.88M

52W High

$4.95

52W Low

$0.85

P/E Ratio

-

50 Day MA

$2.98

200 Day MA

$1.61

Beta

1.15

Dividend Yield

-

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/2/2026$4.30$4.47$4.03$4.23$4.2334,102
10/30/2026$4.42$4.44$4.30$4.30$4.3021,100
10/29/2026$4.40$4.40$4.33$4.40$4.403,565
10/28/2026$4.40$4.44$4.30$4.30$4.307,609
10/27/2026$4.00$4.48$4.00$4.44$4.445,200
10/26/2026$4.00$4.44$4.00$4.40$4.4012,800
10/23/2026$4.04$4.20$3.83$4.20$4.202,980
10/22/2026$4.40$4.40$4.30$4.30$4.302,869
10/21/2026$4.40$4.40$4.39$4.40$4.402,655
10/20/2026$4.39$4.44$4.24$4.40$4.406,710

Analyst Price Targets

Based on analyst covering MPH · as of Sep 17, 2026

📉

Wall Street analysts forecast MPH stock price to fall 33.8% over the next 12 months.

Consensus

Bearish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$2.80

-33.8% Upside

Current Price

C$4.23

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MPH's historical volatility

HistoricalForecast68%95%
C$0.87C$3.48C$6.08C$8.69C$11.29C$13.90TodayApr 23Aug 21Nov 2Dec 15Jan 28Mar 12

30-Day Vol

82.1%

Annualized

90-Day Vol

129.1%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$5.06

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$4.49C$3.38 – C$5.96
60 trading daysC$4.76C$3.19 – C$7.11
90 trading daysC$5.06C$3.10 – C$8.26

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Medicure Inc

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order, and online pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Financials

Revenue (TTM)
$32.08M
EBITDA
$-5.62M
Profit Margin
-23.23%
ROE (TTM)
-49.88%
EPS (Diluted)
-0.71
Book Value
1.11

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Common Questions About MPH

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
TNXTenX Protocols Inc.$48.94+65153.33%
BER-HBE Resources Inc$0.04+300.00%
GOST-PGeorgia Street Capital Corp.$0.27+100.00%
RCR-PCanna 8 Investment Trust$0.01+100.00%
WAVEWaverley Pharma Inc$0.02+100.00%
TRANClean Energy Transition Inc.$0.04+60.00%
CELLGrid Battery Metals Inc.$0.01+50.00%
ELMElement Lifestyle Retirement Inc$0.01+50.00%

MPH.V news timeline

15 articles covering MPH.V, most recent first

Latest

TSX & TSXV small caps leading the week — October 15, 2026

•Investing